Pharmaceutical giant Pfizer expanded its profile on Monday to access cancer treatments.
Why would the COVID-19 jab manufacturer need to specialize in cancer treatments?
Perhaps it’s another case of Big Pharma providing the ‘cure’ for the illness they created?
Pfizer announced that it acquired Seagen, a biotech firm that specializes in innovative cancer treatments, for $43 billion.
The Pharma giant said it would pay $229 a share in cash.
“We are not buying the golden eggs,” Pfizer CEO Albert Bourla reportedly said.
“We are acquiring the goose that is laying the golden eggs.”
NEW – Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billionhttps://t.co/ehJeRSskIM
— Insider Paper…